by Arkadi Mazin – Lifespan Research Institute

Advancements in science don’t always align with changes in policy.

Rhe last installment in our end-of-year series of expert roundups might be the least flashy, but it is arguably no less important than the previous ones dedicated to longevity biotech and geroscience.

Public advocacy is a powerful lever. To quote Abraham Lincoln: “Public sentiment is everything. With it, nothing can fail; against it, nothing can succeed.”

Wide public support could turn longevity into the next global moonshot project, with governments dedicating immense resources and creating a favorable regulatory climate, while the public pushes for faster change. Currently, we are far from this point, but the tide might be turning.

We asked six prominent figures in longevity advocacy to share their thoughts on the movement’s ups and downs in 2025 and its prospects going into 2026.

READ MORE –  Click  here to view the full article